The Team

Scientific Advisory Board

Chair of Scientific Advisory Board

Prof. Jaromír Pastorek, DSc.

Professor Jaromír Pastorek is an excellent Slovak biochemist, pedagogue, and discoverer of the gene encoding a protein CA IX which serves as an endogenous marker of hypoxia in tumors. At present, prof. Pastorek is a Principal Investigator at the Biomedical Research Center of Slovak Academy of Sciences (BMC SAS). Prof. Pastorek was the President of Slovak Academy of Sciences from 2009 until 2015. Formerly he also served as the Plenipotentiary of the Slovak Government for Research and Innovation.

Jaromír Pastorek is a Member of the Board of the Slovak Society for Biochemistry and Molecular Biology from 1998. He is the Member of the European Cancer Research Association (EACR), the Member of the Commission for the PhD degree in Molecular biology and Virology, the Elected member of the European Academy of Sciences and Arts (2008), and member of several others international scientific committees and organizations. He is the coinventor on US patent “MN Gene and Protein” (Zavada, Pastorekova, Pastorek) No. 5,384,676 issued in 1995 and on further 50 patents related to different aspect of MN protein (now named CA IX).

Prof. Pastorek’s research activities are focused on the identification and research of cancer diagnostic and therapeutic targets. His main scientific interest is the analysis of molecular mechanisms of adaptive response to hypoxia and acidosis during tumor development. He is a Principal Investigator of several research projects related to clinical use of CA IX. Prof. Pastorek has published over 185 papers, books, book chapters, and reviews.

h-index: 51

Scientific Advisory Board Member

Prof. Seppo Parkkila, M.D., Ph.D.

Professor Parkkila Seppo Matti Olavi is a Professor of anatomy and Vice-rector (research) at the University of Tampere, Finland. He graduated from the University of Oulu in 1991 (MD) and obtained his PhD-degree in 1994 under the supervision of Professor Hannu Rajaniemi. Between 1996-1998 he worked as a visiting researcher in the laboratory of Professor William S. Sly at Saint Louis University. He became a specialist physician in Clinical Chemistry in 2001. In 2002 he moved to the University of Tampere, where he was appointed for the post of Professor of Medical Technology and Biotechnology, and later in 2008, for the post of Professor of Anatomy.

He has been a Vice-chairman at the School of Medicine in Tampere and a director of MD-PhD program at the same institution. He was awarded with several prizes, e.g. Medix-award in 1992, Carl Bertil Laurell-award in 1998, Dako-award in 1999, and the Teacher of the Year of School of Medicine, University of Tampere every year from 2008 to 2015. Prof. Parkkila is the coinventor on patents – Treatment of Mammalian disorders mediated by alpha-carbonic anhydrase isoforms.

His research work focuses on pH-regulation, carbonic anhydrases and regulation of iron homeostasis. Professor Parkkila has published over 200 articles in international journals and has a wide network of research collaborators around the world.

h-index: 54

Scientific Advisory Board Member

Prof. Silvia Pastorekova, DSc.

Professor Silvia Pastoreková is an excellent Slovak virologist, scientist and pedagogue. Since 2016, she serves as a Director of the Biomedical Research Centre of Slovak Academy of Sciences (BMC SAS) and Head of the Department of Tumor Biology at the Institute of Virology BMC SAS. She is the coinventor on US patent “MN Gene and Protein” (Zavada, Pastorekova, Pastorek) No. 5,384,676 issued in 1995 and on further 50 patents related to different aspect of MN protein (now named CA IX).

She was awarded with several prizes, e.g. the Crystal Wing in category Medicine and Science in 2005, the Slovak Woman of the Year 2009, and The Academia of Education Award in 2010 for her contribution to science, education and popularization. As principal investigator, she participated in two project – the EU’s 6th and 7th Framework Programme (EUROXY and METOXIA), two Marie Curie training networks (CELLCHECK and EngCaBra) and several additional national and international projects. Since 2004, prof. Pastoreková is a Member of the Pathobiology Group of the European Organisation for Research and Treatment of Cancer (EORTC). Since 2006, she is a Representative of the Slovak Republic in the inter-governmental organization The European Molecular Biological Conference (EMBC). In 2017, she was nominated as chairwoman of the International Society for Cancer Metabolism (ISCaM).

Her research work focuses on the role of tumor microenvironment in cancer progression through study the mechanisms of tumor cell adaptation to hypoxia and acidosis. Prof. Pastoreková has published over 190 papers, books, book chapters, and reviews.

h-index: 50

Scientific Advisory Board Member

Dr. Bořivoj Vojtěšek, DSc.

Dr. Vojtěšek is the scientific director at Masaryk Memorial Cancer Institute (MMCI) (formerly Research Institute of Clinical and Experimental Oncology, RICEO) in Brno, Czech Republic. Before he became director, he headed the Department of Cellular and Molecular Oncology, then the Division of Molecular and Experimental Pathology at MMCI. During the period 1992-1993, he visited CRC laboratories at University of Dundee in United Kingdom within the long-term fellowship supported by EMBO (European Molecular Biology Organization) and since 1994 he attended 22 short-term (2-22 weeks) fellowships. Before years 2005 and 2006, he was employed as visiting scientist at IMCB, A-star, Singapore.

Dr. Vojtěšek was one of the team members, who won Arnnold Beckman´s award for the best proteomic publication in 2009. In 2012, he was awarded by the Czech Ministry of Health for scientific work during the period 2009–2011. Dr. Vojtěšek is a member of Learned Society of the Czech Republic, Czech Oncological Association and Czech Medical Association of Jan Evangelista Purkyne.

His research is mainly focused on the study of p53, its homologues, stress proteins and cellular signalling in the malignant transformation. He is a author and co-author 242 scientific reports published in international journals indexed at Web of Science with a total of 7,573 citations without self-citations.

h-index: 47

Scientific Advisory Board Member

Prof. Ján Danko, M.D., Ph.D.

Professor Ján Danko is an excellent Slovak doctor, scientist and pedagogue. He is a Dean of the Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava (JLF UK). He helds the post of President of the Slovak Society of Gynecology and Obstetrics, the IInd Vice-president of the Slovak Medical Association (SkSA), and the Chairman of the Scientific Board of the Ministry of Health of the Slovak Republic.

As Dean of JLF UK, Ján Danko has initiated the realization of several major projects of the JLF UK, e.g. Competence Center, Centers of Excellence as well as the historically most important project: Biomedical Center Martin (BioMed Martin). Currently, BioMed Martin is one of the top excellent research centers for molecular medicine, oncology, respirology and neuroscience in Central Europe. Ján Danko is a member of the Scientific Boards of five foreign universities and member of several Editorial Boards of both, domestic and foreign professional periodicals. He was awarded several prizes, e.g. the Zurich University Award for Scientific Discovery in 1980, the Gold Medal of the Comenius University in Bratislava, the Crystal Wing in category Medicine and Science in 2003, and the Bronze Medal of J. E. Purkyňa.

His scientific work is focused on the prevention of cancer in women and other diseases in gynecology and obstetrics, diagnostic medical sonography as well as the treatment of postpartum anemia with erythropoietin. Ján Danko has published over 680 papers, books, book chapters, and reviews.

h-index: 19

Scientific Advisory Board Member

Assoc. Prof. Richard Imrich, M.D., DSc.

Assoc. professor Richard Imrich is the General Director of the National Institute of Rheumatic Diseases and Chief of Human Endocrinology Laboratory at the Biomedical Research Center of Slovak Academy of Sciences. Between 2005 and 2008 he worked on research in neurological autoimmune syndromes at the National Institute of Health (Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke) in Bethesda, Maryland, USA. During his stay in US, he also worked on several clinical projects including Plasma Exchange for Autoimmune Autonomic Failure and Clinical and Laboratory Assessment of the Autonomic Nervous System in Primary Sjogren’s Syndrome. Since 2008 till 6/2013, he was the Director of the Molecular and Medical Center of Slovak Academy of Sciences and during the period 2013-1/2015 he held the position of Vice-president of Slovak Academy of Sciences.

Richard Imrich is an expert in the research of rheumatic, metabolic and neurological diseases with a focus on the study of neuroendocrine, metabolic and immune changes at the beginning and during the disease.

h-index: 19


MABPRO, a.s.
Dúbravská cesta 2
(Westend Tower)
841 04 Bratislava
Slovak Republic

ID. No.: 36 831 930
VAT Reg. No.: SK2022456678
Registered in Commercial register of Bratislava I District Court
Section: Sa, file no.: 6337/B